Academic society to retract push for eugenic protection law 66 yrs after its proposal
By Norikazu Chiba,
The Mainichi
| 12. 19. 2018
TOKYO -- The Japanese Society for Hygiene, which was active in promoting eugenic policies under the now-defunct eugenic protection law, has decided to retract its proposal made 66 years ago to the government for the use of forced sterilization operations as a means of population control, judging that the move was discriminatory.
It will be the first official admission of a mistake by an academic society among several, such as those for psychiatric medicine or social sciences, which supported sterilization operations against people with mental or physical disabilities that were deemed very serious or hereditary. As many as 25,000 people are believed to have received such surgeries under the 1948-1996 law that is now deemed inhuman, and multiple political parties are putting together a plan to compensate those victims.
Chairman Takemi Otsuki of the society, who also serves as professor of hygiene at Kawasaki Medical School, explains that the society reached the decision as measures have been taken to support the victims of forced sterilization operations. "We want to play a new role to stem the decline in the number...
Related Articles
Since the “CRISPR babies” scandal in 2018, no additional genetically modified babies are known to have been born. Now several techno-enthusiastic billionaires are setting up privately funded companies to genetically edit human embryos, with the explicit intention of creating genetically modified children.
Heritable genome editing remains prohibited by policies in the overwhelming majority of countries that have any relevant policy, and by a binding European treaty. Support for keeping it legally off limits is widespread, including among scientists...
By Ed Cara, Gizmodo | 06.22.2025
In late May, several scientific organizations, including the International Society for Cell and Gene Therapy (ISCT), banded together to call for a 10-year moratorium on using CRISPR and related technologies to pursue human heritable germline editing. The declaration also outlined...
By Isabel van Brugen, Newsweek | 06.05.2025
A U.S.-based biotech company has unveiled a new in vitro fertilization (IVF) option that allows parents to select embryos based on genetic markers tied to health and longevity.
DNA testing and analysis company Nucleus Genomics has announced the world's first...
By Jonathan D. Grinstein, PhD, Inside Precision Medicine | 06.03.2025
On Tuesday, 307 days after he was first admitted to Children’s Hospital of Philadelphia (CHOP), KJ Muldoon went home after being successfully treated with the first personalized CRISPR gene editing therapy. KJ, who was born with a serious and...